237 filings
Page 11 of 12
8-K
4vj97folv90nexf4q g3
18 Mar 15
Nevro Reports Fourth Quarter and Full Year 2014 Financial Results
12:00am
S-8
2z5y2 5arq0
18 Mar 15
Registration of securities for employees
12:00am
10-K
kg862s42
18 Mar 15
Annual report
12:00am
8-K
cdb82jdom9 qsl747kuj
9 Mar 15
Entry into a Material Definitive Agreement
12:00am
8-K
o4ikksnuxc
2 Mar 15
Nevro Appoints Dr. Brad Vale to its Board of Directors
12:00am
8-K
2j5hv7x5b6r57c184hu
23 Jan 15
Nevro Receives Approvable Letter from U.S. Food and Drug Administration for Senza® Spinal Cord Stimulation System
12:00am
10-Q
n3jedkr9ssc1jiyubw
2 Dec 14
Quarterly report
12:00am
8-K
74rme4ei8m meotk
2 Dec 14
Nevro Reports Third Quarter Financial Results
12:00am
S-8
mea7p
12 Nov 14
Registration of securities for employees
12:00am
8-K
eatsgcp dqo1omu
12 Nov 14
Nevro Corp. Announces Full Exercise of Over-Allotment Option and Closing of Initial Public Offering
12:00am
FWP
j5lszw 1b
6 Nov 14
Free writing prospectus
12:00am
424B4
80rcktdajc
6 Nov 14
Prospectus supplement with pricing info
12:00am
CT ORDER
jqc9f
6 Nov 14
Confidential treatment order
12:00am
EFFECT
lrndsc 90
5 Nov 14
Notice of effectiveness
12:00am
S-1MEF
ehxoi 3wy91
5 Nov 14
Registration of additional securities for an S-1
12:00am
CORRESP
1qqefl1
3 Nov 14
Correspondence with SEC
12:00am
CORRESP
kdkb3
3 Nov 14
Correspondence with SEC
12:00am
CERTNYS
09i2a390rhbdj3bqn
31 Oct 14
Certification of approval for NYSE listing
12:00am
8-A12B
ppl yz7cv
30 Oct 14
Registration of securities on exchange
12:00am